Getein Biotech, Inc (SHA:603387)
8.04
+0.04 (0.50%)
Apr 24, 2025, 2:45 PM CST
Getein Biotech Revenue
Getein Biotech had revenue of 262.16M CNY in the quarter ending September 30, 2024, a decrease of -11.91%. This brings the company's revenue in the last twelve months to 1.25B, down -13.67% year-over-year. In the year 2023, Getein Biotech had annual revenue of 1.37B, down -24.85%.
Revenue (ttm)
1.25B
Revenue Growth
-13.67%
P/S Ratio
3.27
Revenue / Employee
497.62K
Employees
2,508
Market Cap
4.08B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.37B | -452.70M | -24.85% |
Dec 31, 2022 | 1.82B | 420.16M | 29.97% |
Dec 31, 2021 | 1.40B | 278.37M | 24.78% |
Dec 31, 2020 | 1.12B | 155.13M | 16.02% |
Dec 31, 2019 | 968.20M | 281.97M | 41.09% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.77B |
Aier Eye Hospital Group | 20.62B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |